RxDoctor Payments Data

Paul Greenberg, DPM

Foot Surgery · New York, NYNPI 1134123110

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,108 of the $4,347 with a category attached, or 71.5%. 22 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 29.3% of the total. Reporting peaked in 2020 at $1,332 and has fallen 68.1% since, to $425 in 2025.

$4,347in general payments, 2019–2025

Across 65 payments — averaging $66.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Treace Medical Concepts, Inc.$663
  • Stryker$610
  • Johnson & Johnson$369
  • Extremity Medical$200
  • Arteriocyte Medical Systems, Inc.$173
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,10872%
  • Education$1,23928%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,347 in reported general payments places this provider in the 85th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$143,268
Medicare patients
694
Services billed
1,344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Econazole Nitrate68$1,518
Ketoconazole22$296
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$217
Meloxicam23$106

Paid to pharmacies, not to this prescriber.

Other foot surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →